Home » NY Court Sends CSHL Suit Against One-Time Patent Counsel to Mass.

NY Court Sends CSHL Suit Against One-Time Patent Counsel to Mass.

Jan 27, 2011
Premium

By Doug Macron

The New York District Court hearing a lawsuit filed by Cold Spring Harbor Laboratory against its former patent counsel has found the venue improper and has declined to rule on a motion to dismiss the case.

As a result, it will be up to a new court in Massachusetts to rule on CSHL's allegations that the law firm Ropes & Gray mishandled certain RNAi-related intellectual property stemming from the work of Greg Hannon and maintained improper business relationships with RNAi drug developers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

What You Might Learn

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

From Whales to Urchins to Algae

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

In the Skin

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

This Week in PNAS

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.

Nov
05
Featured Webinar

Overcoming Challenges in Solid Tumor Testing with Advanced AI

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

What's Popular?

In Gene Silencing/Gene Editing

  1. CRISPR Researchers Develop Highly Sensitive Method for Identification of Off-Target Effects In Vivo

  2. Thermo Fisher Licenses CRISPR Patents From Broad Institute, ERS Genomics

  3. Horizon Discovery Revenues Double in H1

  4. Saturation Editing of BRCA1 Exons Reveals Functional, Non-Functional Variants

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.